Wednesday, October 24, 2018
- 11:00AM-12:30PM
-
Abstract Number: 2955
Risk of Neurological Adverse Events during Tumour Necrosis Factor Inhibitor Treatment for Arthritis: A Population-Based Cohort Study from Danbio and the Danish National Patient Registry
6W018 ACR Abstract: Epidemiology & Pub Health IV: Determinants & Consequences of Tx (2952–2957)- 11:00AM-12:30PM
-
Abstract Number: 2971
Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease: Long Term Outcomes
6W021 ACR Abstract: Misc Rheumatic & Inflam DZ II (2970–2975)- 11:00AM-12:30PM
-
Abstract Number: 2968
Role of Choline in Gouty Inflammation
6W020 ACR Abstract: Metabolic & Crystal Arthropathies–Basic Science & Imaging (2964–2969)- 11:00AM-12:30PM
-
Abstract Number: 2957
Socioeconomic Differences in Opioid Use By People with Inflammatory Arthritis
6W018 ACR Abstract: Epidemiology & Pub Health IV: Determinants & Consequences of Tx (2952–2957)- 11:00AM-12:30PM
-
Abstract Number: 2946
T Peripheral Helper Cells Are Expanded in the Circulation of Active SLE Patients and Correlate with CD21low B Cells
6W024 ACR Abstract: SLE–Etiology & Pathogenesis II (2946–2951)- 11:00AM-12:30PM
-
Abstract Number: 2965
Targeting Glucose Metabolism in the Murine Air Pouch Model of Acute Gouty Inflammation
6W020 ACR Abstract: Metabolic & Crystal Arthropathies–Basic Science & Imaging (2964–2969)- 11:00AM-12:30PM
-
Abstract Number: 2983
The Changing Faces of Rheumatoid Arthritis Patients at Presentation: A 20-Year Study
6W023 ACR Abstract: RA–DX, Manifestations, & Outcomes VI: Outcomes Reports (2982–2987)- 11:00AM-12:30PM
-
Abstract Number: 2996
The Economic Burden of Systemic Lupus Erythematosus (SLE) within a Medicaid Cohort Stratified By Disease Severity
6W027 ACR/ARHP Abstract: Health Services Research II: Economic & Clinical Implications (2994–2999)- 11:00AM-12:30PM
-
Abstract Number: 2986
The Impact of Exercise and Clinical Factors on Perceived Cognitive Function in Patients with Rheumatoid Arthritis: Results from a Prospective Cohort Study
6W023 ACR Abstract: RA–DX, Manifestations, & Outcomes VI: Outcomes Reports (2982–2987)- 11:00AM-12:30PM
-
Abstract Number: 2966
Ultrasound Shows Rapid Reduction of Uric Load during Treat-to-Target Approach in Gout Patients: Results from a Longitudinal Study
6W020 ACR Abstract: Metabolic & Crystal Arthropathies–Basic Science & Imaging (2964–2969)- 11:00AM-12:30PM
-
Abstract Number: 2951
Ustekinumab Treatment Response in SLE Is Associated with Changes in Type II but Not Type I Interferons
6W024 ACR Abstract: SLE–Etiology & Pathogenesis II (2946–2951)- 11:00AM-12:30PM
-
Abstract Number: 2993
Vascular Involvement in Behcet’s Syndrome May be Associated with Subclinical Atherosclerosis